Patents Assigned to Population Council, Inc.
  • Publication number: 20240358633
    Abstract: The present disclosure describes a vaginal system comprising segesterone acetate and ethinyl estradiol configured for thirteen 28-day product-use cycles that is compatible with male condoms comprising natural rubber latex, polyisoprene, or polyurethane and a method of providing birth control using the vaginal system wherein a secondary contraception is employed when the vaginal system is removed or expelled from the vagina for specified amounts of time during any of the product-use cycles.
    Type: Application
    Filed: December 8, 2023
    Publication date: October 31, 2024
    Applicant: The Population Council, Inc.
    Inventors: George William CREASY, II, Ruth Beverly MERKATZ, Bruce VARIANO
  • Patent number: 11850251
    Abstract: The present disclosure relates to a vaginal system that prevents pregnancy comprised of segesterone acetate and ethinyl estradiol and is configured for thirteen 28-day product-use cycles.
    Type: Grant
    Filed: March 1, 2021
    Date of Patent: December 26, 2023
    Assignee: The Population Council, Inc.
    Inventor: Bruce Variano
  • Patent number: 11793669
    Abstract: The present invention provides improved intravaginal drug delivery devices, i.e., intravaginal rings, useful for the prophylactic administration of dapivirine in combination with either an antimicrobial compound or a contraceptive to a human. The present invention also provides methods of blocking DNA polymerization by an HIV reverse transcriptase enzyme, methods of preventing HIV infection in a female human, methods of treating HIV infection in a female human, methods of preventing unintended pregnancy in a female human, and methods of preparing intravaginal rings.
    Type: Grant
    Filed: January 18, 2022
    Date of Patent: October 24, 2023
    Assignee: The Population Council, Inc.
    Inventors: Brid Devlin, Jonathon Daryll Holt, Andrew Nathan Brimer, Jeremy Peter Nuttall, Karl Malcolm, Susan Margaret Fetherston, Peter John James Boyd
  • Publication number: 20230240982
    Abstract: The present disclosure relates to a vaginal system that prevents pregnancy comprised of segesterone acetate and ethinyl estradiol and is configured for thirteen 28-day product-use cycles.
    Type: Application
    Filed: December 2, 2022
    Publication date: August 3, 2023
    Applicant: The Population Council, Inc.
    Inventor: Bruce VARIANO
  • Patent number: 11529308
    Abstract: The present disclosure relates to a vaginal system that prevents pregnancy comprised of segesterone acetate and ethinyl estradiol and is configured for thirteen 28-day product-use cycles.
    Type: Grant
    Filed: August 17, 2020
    Date of Patent: December 20, 2022
    Assignee: The Population Council, Inc.
    Inventor: Bruce Variano
  • Patent number: 11331370
    Abstract: Disclosed are compositions for inhibiting transmission of a sexually transmitted infection that contain one or more polyanionic microbicides, such as carrageenans, including lambda carrageenan, as well as water-soluble metal salts and specified lectins. Also disclosed are methods for making and using the compositions.
    Type: Grant
    Filed: November 6, 2018
    Date of Patent: May 17, 2022
    Assignees: The Population Council, Inc., The United States of America
    Inventors: Barry R. O'Keefe, Melissa Robbiani, José A. Fernández Romero
  • Publication number: 20220054503
    Abstract: The present disclosure relates to a vaginal system that prevents pregnancy comprised of segesterone acetate and ethinyl estradiol and is configured for thirteen 28-day product-use cycles.
    Type: Application
    Filed: November 5, 2021
    Publication date: February 24, 2022
    Applicant: The Population Council, Inc.
    Inventor: Bruce VARIANO
  • Publication number: 20210290637
    Abstract: The present disclosure relates to a vaginal system that prevents pregnancy comprised of segesterone acetate and ethinyl estradiol and is configured for thirteen 28-day product-use cycles.
    Type: Application
    Filed: March 1, 2021
    Publication date: September 23, 2021
    Applicant: The Population Council, Inc.
    Inventor: Bruce VARIANO
  • Patent number: 10940157
    Abstract: The present disclosure relates to a vaginal system that prevents pregnancy comprised of segesterone acetate and ethinyl estradiol and is configured for thirteen 28-day product-use cycles.
    Type: Grant
    Filed: March 10, 2020
    Date of Patent: March 9, 2021
    Assignee: The Population Council, Inc.
    Inventor: Bruce Variano
  • Patent number: 10925882
    Abstract: The present disclosure relates to a vaginal system that prevents pregnancy comprised of segesterone acetate and ethinyl estradiol and is configured for thirteen 28-day product-use cycles.
    Type: Grant
    Filed: March 23, 2020
    Date of Patent: February 23, 2021
    Assignee: The Population Council, Inc.
    Inventor: Bruce Variano
  • Patent number: 10918649
    Abstract: The present disclosure relates to a vaginal system that prevents pregnancy comprised of segesterone acetate and ethinyl estradiol and is configured for thirteen 28-day product-use cycles.
    Type: Grant
    Filed: June 21, 2019
    Date of Patent: February 16, 2021
    Assignee: The Population Council, Inc.
    Inventor: Bruce Variano
  • Publication number: 20200397692
    Abstract: The present disclosure relates to a vaginal system that prevents pregnancy comprised of segesterone acetate and ethinyl estradiol and is configured for thirteen 28-day product-use cycles.
    Type: Application
    Filed: August 17, 2020
    Publication date: December 24, 2020
    Applicant: The Population Council, Inc.
    Inventor: Bruce VARIANO
  • Publication number: 20200397802
    Abstract: The present disclosure relates to a vaginal system that prevents pregnancy comprised of segesterone acetate and ethinyl estradiol and is configured for thirteen 28-day product-use cycles.
    Type: Application
    Filed: March 23, 2020
    Publication date: December 24, 2020
    Applicant: The Population Council, Inc.
    Inventor: Bruce VARIANO
  • Patent number: 10780047
    Abstract: The present disclosure describes a vaginal system comprising segesterone acetate and ethinyl estradiol configured for thirteen 28-day product-use cycles that is compatible with male condoms comprising natural rubber latex, polyisoprene, or polyurethane and a method of providing birth control using the vaginal system wherein a secondary contraception is employed when the vaginal system is removed or expelled from the vagina for specified amounts of time during any of the product-use cycles.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: September 22, 2020
    Assignee: The Population Council, Inc.
    Inventors: George William Creasy, II, Ruth Beverly Merkatz
  • Patent number: 10765628
    Abstract: The present disclosure describes a vaginal system comprising segesterone acetate and ethinyl estradiol configured for thirteen 28-day product-use cycles that is compatible with male condoms comprising natural rubber latex, polyisoprene, or polyurethane and a method of providing birth control using the vaginal system wherein a secondary contraception is employed when the vaginal system is removed or expelled from the vagina for specified amounts of time during any of the product-use cycles.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: September 8, 2020
    Assignee: The Population Council, Inc.
    Inventors: George William Creasy, II, Ruth Beverly Merkatz
  • Patent number: 10632066
    Abstract: The present disclosure describes a vaginal system comprising segesterone acetate and ethinyl estradiol configured for thirteen 28-day product-use cycles that is compatible with male condoms comprising natural rubber latex, polyisoprene, or polyurethane and a method of providing birth control using the vaginal system wherein a secondary contraception is employed when the vaginal system is removed or expelled from the vagina for specified amounts of time during any of the product-use cycles.
    Type: Grant
    Filed: February 1, 2019
    Date of Patent: April 28, 2020
    Assignee: The Population Council, Inc.
    Inventors: George William Creasy, II, Ruth Beverly Merkatz
  • Publication number: 20190070253
    Abstract: Disclosed are compositions for inhibiting transmission of a sexually transmitted infection that contain one or more polyanionic microbicides, such as carrageenans, including lambda carrageenan, as well as water-soluble metal salts and specified lectins. Also disclosed are methods for making and using the compositions.
    Type: Application
    Filed: November 6, 2018
    Publication date: March 7, 2019
    Applicants: The Population Council, Inc., The United States of America
    Inventors: Barry R. O'Keefe, Melissa Robbiani, José A. Fernández Romero
  • Patent number: 10143721
    Abstract: Disclosed are compositions for inhibiting transmission of a sexually transmitted infection that contain one or more polyanionic microbicides, such as carrageenans, including lambda carrageenan, as well as water-soluble metal salts and specified lectins. Also disclosed are methods for making and using the compositions.
    Type: Grant
    Filed: January 13, 2015
    Date of Patent: December 4, 2018
    Assignees: The Population Council, Inc., The United States of America, as represented by the Secretary, Dept. of Health and Human Services
    Inventors: Barry R. O'Keefe, Melissa Robbiani, José A. Fernández Romero
  • Patent number: 10052335
    Abstract: Methods for treating neurodegeneration and/or myelination in patients are disclosed comprising treating the patient with a progestin compound which exerts binding to progesterone receptors and elicits progesterone-receptor-induced biological responses without interacting with the androgen receptor and without inducing androgen or glucocorticoid biological responses at a dosage sufficient to prevent or reduce neurodegeneration. The progestin compound preferably comprises 16-methylene-17?-acetoxy-19-norpregn-4-ene-3,20-dione, and the methods include combining the progestin compound with an estrogen compound to provide both contraception and treatment for myelin repair and neurodegeneration.
    Type: Grant
    Filed: October 19, 2010
    Date of Patent: August 21, 2018
    Assignee: The Population Council, Inc.
    Inventors: Regine Sitruk-Ware, Michael Maria Helmut Schumacher, Roberta Brinton, Martine El-Etr, Abdelmouman Ghoumari, Rachida Guennoun
  • Patent number: D935018
    Type: Grant
    Filed: April 7, 2020
    Date of Patent: November 2, 2021
    Assignee: The Population Council, Inc.
    Inventor: Bruce Variano